recent articles
Live Webinar Event: Wednesday, April 28, 2018 Register your team here Compliance with CLIA and other regulations is getting tougher and more complex. Many labs report that assessments and CLIA inspections of their labs are becoming more...
In 2010, results of a phase 3 randomized controlled trial showed that targeted therapy directed against HER2 statistically significantly prolonged overall survival compared with chemotherapy alone in patients with HER2–positive...
© 2023 Tissuepathology.com. All rights reserved. Millennial Consulting. | Web Design by Zealth Digital Marketing